
NATURE . COM {
}
Title:
Antigen glycosylation regulates efficacy of CAR T cells targeting CD19 | Nature Communications
Description:
While chimeric antigen receptor (CAR) T cells targeting CD19 can cure a subset of patients with B cell malignancies, most patients treated will not achieve durable remission. Identification of the mechanisms leading to failure is essential to broadening the efficacy of this promising platform. Several studies have demonstrated that disruption of CD19 genes and transcripts can lead to disease relapse after initial response; however, few other tumor-intrinsic drivers of CAR T cell failure have been reported. Here we identify expression of the Golgi-resident intramembrane protease Signal peptide peptidase-like 3 (SPPL3) in malignant B cells as a potent regulator of resistance to CAR therapy. Loss of SPPL3 results in hyperglycosylation of CD19, an alteration that directly inhibits CAR T cell effector function and suppresses anti-tumor cytotoxicity. Alternatively, over-expression of SPPL3 drives loss of CD19 protein, also enabling resistance. In this pre-clinical model these findings identify post-translational modification of CD19 as a mechanism of antigen escape from CAR T cell therapy. Loss of surface CD19 expression by leukemic cells leads to resistance and relapse to CD19-targeted CAR-T therapies. Here the authors show that loss of SPPL3 in malignant B cells results in hyperglycosylation of CD19.
Website Age:
30 years and 10 months (reg. 1994-08-11).
Matching Content Categories {📚}
- Science
- Education
- Insurance
Content Management System {📝}
What CMS is nature.com built with?
Custom-built
No common CMS systems were detected on Nature.com, and no known web development framework was identified.
Traffic Estimate {📈}
What is the average monthly size of nature.com audience?
🌠 Phenomenal Traffic: 5M - 10M visitors per month
Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Nature.com Make Money? {💸}
Display Ads {🎯}
The website utilizes display ads within its content to generate revenue. Check the next section for further revenue estimates.
Ads are managed by yourbow.com. Particular relationships are as follows:
Direct Advertisers (10)
google.com, pmc.com, doceree.com, yourbow.com, audienciad.com, onlinemediasolutions.com, advibe.media, aps.amazon.com, getmediamx.com, onomagic.comReseller Advertisers (38)
conversantmedia.com, rubiconproject.com, pubmatic.com, appnexus.com, openx.com, smartadserver.com, lijit.com, sharethrough.com, video.unrulymedia.com, google.com, yahoo.com, triplelift.com, onetag.com, sonobi.com, contextweb.com, 33across.com, indexexchange.com, media.net, themediagrid.com, adform.com, richaudience.com, sovrn.com, improvedigital.com, freewheel.tv, smaato.com, yieldmo.com, amxrtb.com, adyoulike.com, adpone.com, criteo.com, smilewanted.com, 152media.info, e-planning.net, smartyads.com, loopme.com, opera.com, mediafuse.com, betweendigital.comHow Much Does Nature.com Make? {💰}
Display Ads {🎯}
$63,100 per month
Our calculations suggest that Nature.com earns between $42,042 and $115,616 monthly online from display advertisements.
Keywords {🔍}
cells, nalm, cell, car, spplko, sppl, fig, article, cart, glycosylation, data, loss, resistance, google, scholar, protein, binding, cas, antigen, studies, expression, nature, efficacy, supplementary, therapy, performed, antibody, analysis, cancer, clone, source, diluted, standard, min, results, function, activation, representative, experiments, fmc, med, hyperglycosylation, surface, combined, time, research, university, targeting, patients, demonstrated,
Topics {✒️}
nature portfolio privacy policy genome editing phyre2 web portal xenogeneic graft-versus-host disease advertising nature reprints middle german research foundation fluorescence-assisted cell sorting refractory mantle-cell lymphoma genome-wide knockout screen glycosylation-mediated antigen escape crispr/cas9-guide design common post-translational modifications female nod-scid-γc−/− standard dark/light cycles research design suppresses anti-tumor cytotoxicity single-cell transcriptional profiling lonza 4d-nucleofector core/ peer review reporting summary cd19-targeted car immunotherapy 2 ul anti-cd19 antibody car antigen-binding domain anti-cancer cellular therapy include post-translation modifications b-cell lymphoblastic leukemia full-length cd19 protein martina haug-kroeper oci-ly10 cells revealed chimeric antigen receptors identify post-translational modifications car-t-cell therapy permissions regulates cellular n-glycosylation 4-1bb-costimulated cd22 car clear cd19-negative population research conducted exploratory research antigen-independent activation enhances achieve long-term remission pathogen-free conditions oci-ly10 cells probed pooled library full size image crispr/cas9-based loss source data file
Schema {🗺️}
WebPage:
mainEntity:
headline:Antigen glycosylation regulates efficacy of CAR T cells targeting CD19
description:While chimeric antigen receptor (CAR) T cells targeting CD19 can cure a subset of patients with B cell malignancies, most patients treated will not achieve durable remission. Identification of the mechanisms leading to failure is essential to broadening the efficacy of this promising platform. Several studies have demonstrated that disruption of CD19 genes and transcripts can lead to disease relapse after initial response; however, few other tumor-intrinsic drivers of CAR T cell failure have been reported. Here we identify expression of the Golgi-resident intramembrane protease Signal peptide peptidase-like 3 (SPPL3) in malignant B cells as a potent regulator of resistance to CAR therapy. Loss of SPPL3 results in hyperglycosylation of CD19, an alteration that directly inhibits CAR T cell effector function and suppresses anti-tumor cytotoxicity. Alternatively, over-expression of SPPL3 drives loss of CD19 protein, also enabling resistance. In this pre-clinical model these findings identify post-translational modification of CD19 as a mechanism of antigen escape from CAR T cell therapy. Loss of surface CD19 expression by leukemic cells leads to resistance and relapse to CD19-targeted CAR-T therapies. Here the authors show that loss of SPPL3 in malignant B cells results in hyperglycosylation of CD19.
datePublished:2022-06-11T00:00:00Z
dateModified:2022-06-11T00:00:00Z
pageStart:1
pageEnd:11
license:http://creativecommons.org/licenses/by/4.0/
sameAs:https://doi.org/10.1038/s41467-022-31035-7
keywords:
Haematological cancer
Immunotherapy
Tumour immunology
Science
Humanities and Social Sciences
multidisciplinary
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-022-31035-7/MediaObjects/41467_2022_31035_Fig1_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-022-31035-7/MediaObjects/41467_2022_31035_Fig2_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-022-31035-7/MediaObjects/41467_2022_31035_Fig3_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-022-31035-7/MediaObjects/41467_2022_31035_Fig4_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-022-31035-7/MediaObjects/41467_2022_31035_Fig5_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-022-31035-7/MediaObjects/41467_2022_31035_Fig6_HTML.png
isPartOf:
name:Nature Communications
issn:
2041-1723
volumeNumber:13
type:
Periodical
PublicationVolume
publisher:
name:Nature Publishing Group UK
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Amanda Heard
url:http://orcid.org/0000-0002-7150-7998
affiliation:
name:Washington University School of Medicine
address:
name:Division of Oncology, Washington University School of Medicine, Saint Louis, USA
type:PostalAddress
type:Organization
type:Person
name:Jack H. Landmann
affiliation:
name:Washington University School of Medicine
address:
name:Division of Oncology, Washington University School of Medicine, Saint Louis, USA
type:PostalAddress
type:Organization
type:Person
name:Ava R. Hansen
url:http://orcid.org/0000-0003-1908-6433
affiliation:
name:Washington University School of Medicine
address:
name:Department of Pediatrics, Washington University School of Medicine, Saint Louis, USA
type:PostalAddress
type:Organization
type:Person
name:Alkmini Papadopolou
affiliation:
name:University of Augsburg
address:
name:Biochemistry and Molecular Biology, Institute of Theoretical Medicine, Medical Faculty, University of Augsburg, Augsburg, Germany
type:PostalAddress
type:Organization
type:Person
name:Yu-Sung Hsu
affiliation:
name:Washington University School of Medicine
address:
name:Division of Oncology, Washington University School of Medicine, Saint Louis, USA
type:PostalAddress
type:Organization
type:Person
name:Mehmet Emrah Selli
url:http://orcid.org/0000-0002-3478-8970
affiliation:
name:Washington University School of Medicine
address:
name:Division of Oncology, Washington University School of Medicine, Saint Louis, USA
type:PostalAddress
type:Organization
type:Person
name:John M. Warrington
url:http://orcid.org/0000-0001-6066-5491
affiliation:
name:Washington University School of Medicine
address:
name:Division of Oncology, Washington University School of Medicine, Saint Louis, USA
type:PostalAddress
type:Organization
type:Person
name:John Lattin
affiliation:
name:Washington University School of Medicine
address:
name:Division of Oncology, Washington University School of Medicine, Saint Louis, USA
type:PostalAddress
type:Organization
type:Person
name:Jufang Chang
affiliation:
name:Washington University School of Medicine
address:
name:Division of Oncology, Washington University School of Medicine, Saint Louis, USA
type:PostalAddress
type:Organization
type:Person
name:Helen Ha
affiliation:
name:Washington University School of Medicine
address:
name:Division of Oncology, Washington University School of Medicine, Saint Louis, USA
type:PostalAddress
type:Organization
type:Person
name:Martina Haug-Kroeper
affiliation:
name:University of Augsburg
address:
name:Biochemistry and Molecular Biology, Institute of Theoretical Medicine, Medical Faculty, University of Augsburg, Augsburg, Germany
type:PostalAddress
type:Organization
type:Person
name:Balraj Doray
url:http://orcid.org/0000-0003-3347-5013
affiliation:
name:Washington University School of Medicine
address:
name:Division of Hematology, Washington University School of Medicine, Saint Louis, USA
type:PostalAddress
type:Organization
type:Person
name:Saar Gill
affiliation:
name:University of Pennsylvania School of Medicine
address:
name:Division of Hematology and Oncology, University of Pennsylvania School of Medicine, Philadelphia, USA
type:PostalAddress
type:Organization
type:Person
name:Marco Ruella
url:http://orcid.org/0000-0003-4301-5811
affiliation:
name:University of Pennsylvania School of Medicine
address:
name:Division of Hematology and Oncology, University of Pennsylvania School of Medicine, Philadelphia, USA
type:PostalAddress
type:Organization
type:Person
name:Katharina E. Hayer
affiliation:
name:The Childrenâs Hospital of Philadelphia
address:
name:Department of Biomedical and Health Informatics, The Childrenâs Hospital of Philadelphia, Philadelphia, USA
type:PostalAddress
type:Organization
name:The Childrenâs Hospital of Philadelphia
address:
name:Department of Pathology and Laboratory Medicine, The Childrenâs Hospital of Philadelphia, Philadelphia, USA
type:PostalAddress
type:Organization
type:Person
name:Matthew D. Weitzman
url:http://orcid.org/0000-0001-9713-167X
affiliation:
name:The Childrenâs Hospital of Philadelphia
address:
name:Department of Pathology and Laboratory Medicine, The Childrenâs Hospital of Philadelphia, Philadelphia, USA
type:PostalAddress
type:Organization
name:University of Pennsylvania
address:
name:Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA
type:PostalAddress
type:Organization
type:Person
name:Abby M. Green
affiliation:
name:Washington University School of Medicine
address:
name:Department of Pediatrics, Washington University School of Medicine, Saint Louis, USA
type:PostalAddress
type:Organization
name:Washington University School of Medicine
address:
name:Center for Genome Integrity, Siteman Cancer Center, Washington University School of Medicine, Saint Louis, USA
type:PostalAddress
type:Organization
type:Person
name:Regina Fluhrer
url:http://orcid.org/0000-0002-9778-4643
affiliation:
name:University of Augsburg
address:
name:Biochemistry and Molecular Biology, Institute of Theoretical Medicine, Medical Faculty, University of Augsburg, Augsburg, Germany
type:PostalAddress
type:Organization
type:Person
name:Nathan Singh
url:http://orcid.org/0000-0002-0350-7574
affiliation:
name:Washington University School of Medicine
address:
name:Division of Oncology, Washington University School of Medicine, Saint Louis, USA
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:1
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:Antigen glycosylation regulates efficacy of CAR T cells targeting CD19
description:While chimeric antigen receptor (CAR) T cells targeting CD19 can cure a subset of patients with B cell malignancies, most patients treated will not achieve durable remission. Identification of the mechanisms leading to failure is essential to broadening the efficacy of this promising platform. Several studies have demonstrated that disruption of CD19 genes and transcripts can lead to disease relapse after initial response; however, few other tumor-intrinsic drivers of CAR T cell failure have been reported. Here we identify expression of the Golgi-resident intramembrane protease Signal peptide peptidase-like 3 (SPPL3) in malignant B cells as a potent regulator of resistance to CAR therapy. Loss of SPPL3 results in hyperglycosylation of CD19, an alteration that directly inhibits CAR T cell effector function and suppresses anti-tumor cytotoxicity. Alternatively, over-expression of SPPL3 drives loss of CD19 protein, also enabling resistance. In this pre-clinical model these findings identify post-translational modification of CD19 as a mechanism of antigen escape from CAR T cell therapy. Loss of surface CD19 expression by leukemic cells leads to resistance and relapse to CD19-targeted CAR-T therapies. Here the authors show that loss of SPPL3 in malignant B cells results in hyperglycosylation of CD19.
datePublished:2022-06-11T00:00:00Z
dateModified:2022-06-11T00:00:00Z
pageStart:1
pageEnd:11
license:http://creativecommons.org/licenses/by/4.0/
sameAs:https://doi.org/10.1038/s41467-022-31035-7
keywords:
Haematological cancer
Immunotherapy
Tumour immunology
Science
Humanities and Social Sciences
multidisciplinary
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-022-31035-7/MediaObjects/41467_2022_31035_Fig1_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-022-31035-7/MediaObjects/41467_2022_31035_Fig2_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-022-31035-7/MediaObjects/41467_2022_31035_Fig3_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-022-31035-7/MediaObjects/41467_2022_31035_Fig4_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-022-31035-7/MediaObjects/41467_2022_31035_Fig5_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-022-31035-7/MediaObjects/41467_2022_31035_Fig6_HTML.png
isPartOf:
name:Nature Communications
issn:
2041-1723
volumeNumber:13
type:
Periodical
PublicationVolume
publisher:
name:Nature Publishing Group UK
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Amanda Heard
url:http://orcid.org/0000-0002-7150-7998
affiliation:
name:Washington University School of Medicine
address:
name:Division of Oncology, Washington University School of Medicine, Saint Louis, USA
type:PostalAddress
type:Organization
type:Person
name:Jack H. Landmann
affiliation:
name:Washington University School of Medicine
address:
name:Division of Oncology, Washington University School of Medicine, Saint Louis, USA
type:PostalAddress
type:Organization
type:Person
name:Ava R. Hansen
url:http://orcid.org/0000-0003-1908-6433
affiliation:
name:Washington University School of Medicine
address:
name:Department of Pediatrics, Washington University School of Medicine, Saint Louis, USA
type:PostalAddress
type:Organization
type:Person
name:Alkmini Papadopolou
affiliation:
name:University of Augsburg
address:
name:Biochemistry and Molecular Biology, Institute of Theoretical Medicine, Medical Faculty, University of Augsburg, Augsburg, Germany
type:PostalAddress
type:Organization
type:Person
name:Yu-Sung Hsu
affiliation:
name:Washington University School of Medicine
address:
name:Division of Oncology, Washington University School of Medicine, Saint Louis, USA
type:PostalAddress
type:Organization
type:Person
name:Mehmet Emrah Selli
url:http://orcid.org/0000-0002-3478-8970
affiliation:
name:Washington University School of Medicine
address:
name:Division of Oncology, Washington University School of Medicine, Saint Louis, USA
type:PostalAddress
type:Organization
type:Person
name:John M. Warrington
url:http://orcid.org/0000-0001-6066-5491
affiliation:
name:Washington University School of Medicine
address:
name:Division of Oncology, Washington University School of Medicine, Saint Louis, USA
type:PostalAddress
type:Organization
type:Person
name:John Lattin
affiliation:
name:Washington University School of Medicine
address:
name:Division of Oncology, Washington University School of Medicine, Saint Louis, USA
type:PostalAddress
type:Organization
type:Person
name:Jufang Chang
affiliation:
name:Washington University School of Medicine
address:
name:Division of Oncology, Washington University School of Medicine, Saint Louis, USA
type:PostalAddress
type:Organization
type:Person
name:Helen Ha
affiliation:
name:Washington University School of Medicine
address:
name:Division of Oncology, Washington University School of Medicine, Saint Louis, USA
type:PostalAddress
type:Organization
type:Person
name:Martina Haug-Kroeper
affiliation:
name:University of Augsburg
address:
name:Biochemistry and Molecular Biology, Institute of Theoretical Medicine, Medical Faculty, University of Augsburg, Augsburg, Germany
type:PostalAddress
type:Organization
type:Person
name:Balraj Doray
url:http://orcid.org/0000-0003-3347-5013
affiliation:
name:Washington University School of Medicine
address:
name:Division of Hematology, Washington University School of Medicine, Saint Louis, USA
type:PostalAddress
type:Organization
type:Person
name:Saar Gill
affiliation:
name:University of Pennsylvania School of Medicine
address:
name:Division of Hematology and Oncology, University of Pennsylvania School of Medicine, Philadelphia, USA
type:PostalAddress
type:Organization
type:Person
name:Marco Ruella
url:http://orcid.org/0000-0003-4301-5811
affiliation:
name:University of Pennsylvania School of Medicine
address:
name:Division of Hematology and Oncology, University of Pennsylvania School of Medicine, Philadelphia, USA
type:PostalAddress
type:Organization
type:Person
name:Katharina E. Hayer
affiliation:
name:The Childrenâs Hospital of Philadelphia
address:
name:Department of Biomedical and Health Informatics, The Childrenâs Hospital of Philadelphia, Philadelphia, USA
type:PostalAddress
type:Organization
name:The Childrenâs Hospital of Philadelphia
address:
name:Department of Pathology and Laboratory Medicine, The Childrenâs Hospital of Philadelphia, Philadelphia, USA
type:PostalAddress
type:Organization
type:Person
name:Matthew D. Weitzman
url:http://orcid.org/0000-0001-9713-167X
affiliation:
name:The Childrenâs Hospital of Philadelphia
address:
name:Department of Pathology and Laboratory Medicine, The Childrenâs Hospital of Philadelphia, Philadelphia, USA
type:PostalAddress
type:Organization
name:University of Pennsylvania
address:
name:Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA
type:PostalAddress
type:Organization
type:Person
name:Abby M. Green
affiliation:
name:Washington University School of Medicine
address:
name:Department of Pediatrics, Washington University School of Medicine, Saint Louis, USA
type:PostalAddress
type:Organization
name:Washington University School of Medicine
address:
name:Center for Genome Integrity, Siteman Cancer Center, Washington University School of Medicine, Saint Louis, USA
type:PostalAddress
type:Organization
type:Person
name:Regina Fluhrer
url:http://orcid.org/0000-0002-9778-4643
affiliation:
name:University of Augsburg
address:
name:Biochemistry and Molecular Biology, Institute of Theoretical Medicine, Medical Faculty, University of Augsburg, Augsburg, Germany
type:PostalAddress
type:Organization
type:Person
name:Nathan Singh
url:http://orcid.org/0000-0002-0350-7574
affiliation:
name:Washington University School of Medicine
address:
name:Division of Oncology, Washington University School of Medicine, Saint Louis, USA
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:1
["Periodical","PublicationVolume"]:
name:Nature Communications
issn:
2041-1723
volumeNumber:13
Organization:
name:Nature Publishing Group UK
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:Washington University School of Medicine
address:
name:Division of Oncology, Washington University School of Medicine, Saint Louis, USA
type:PostalAddress
name:Washington University School of Medicine
address:
name:Division of Oncology, Washington University School of Medicine, Saint Louis, USA
type:PostalAddress
name:Washington University School of Medicine
address:
name:Department of Pediatrics, Washington University School of Medicine, Saint Louis, USA
type:PostalAddress
name:University of Augsburg
address:
name:Biochemistry and Molecular Biology, Institute of Theoretical Medicine, Medical Faculty, University of Augsburg, Augsburg, Germany
type:PostalAddress
name:Washington University School of Medicine
address:
name:Division of Oncology, Washington University School of Medicine, Saint Louis, USA
type:PostalAddress
name:Washington University School of Medicine
address:
name:Division of Oncology, Washington University School of Medicine, Saint Louis, USA
type:PostalAddress
name:Washington University School of Medicine
address:
name:Division of Oncology, Washington University School of Medicine, Saint Louis, USA
type:PostalAddress
name:Washington University School of Medicine
address:
name:Division of Oncology, Washington University School of Medicine, Saint Louis, USA
type:PostalAddress
name:Washington University School of Medicine
address:
name:Division of Oncology, Washington University School of Medicine, Saint Louis, USA
type:PostalAddress
name:Washington University School of Medicine
address:
name:Division of Oncology, Washington University School of Medicine, Saint Louis, USA
type:PostalAddress
name:University of Augsburg
address:
name:Biochemistry and Molecular Biology, Institute of Theoretical Medicine, Medical Faculty, University of Augsburg, Augsburg, Germany
type:PostalAddress
name:Washington University School of Medicine
address:
name:Division of Hematology, Washington University School of Medicine, Saint Louis, USA
type:PostalAddress
name:University of Pennsylvania School of Medicine
address:
name:Division of Hematology and Oncology, University of Pennsylvania School of Medicine, Philadelphia, USA
type:PostalAddress
name:University of Pennsylvania School of Medicine
address:
name:Division of Hematology and Oncology, University of Pennsylvania School of Medicine, Philadelphia, USA
type:PostalAddress
name:The Childrenâs Hospital of Philadelphia
address:
name:Department of Biomedical and Health Informatics, The Childrenâs Hospital of Philadelphia, Philadelphia, USA
type:PostalAddress
name:The Childrenâs Hospital of Philadelphia
address:
name:Department of Pathology and Laboratory Medicine, The Childrenâs Hospital of Philadelphia, Philadelphia, USA
type:PostalAddress
name:The Childrenâs Hospital of Philadelphia
address:
name:Department of Pathology and Laboratory Medicine, The Childrenâs Hospital of Philadelphia, Philadelphia, USA
type:PostalAddress
name:University of Pennsylvania
address:
name:Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA
type:PostalAddress
name:Washington University School of Medicine
address:
name:Department of Pediatrics, Washington University School of Medicine, Saint Louis, USA
type:PostalAddress
name:Washington University School of Medicine
address:
name:Center for Genome Integrity, Siteman Cancer Center, Washington University School of Medicine, Saint Louis, USA
type:PostalAddress
name:University of Augsburg
address:
name:Biochemistry and Molecular Biology, Institute of Theoretical Medicine, Medical Faculty, University of Augsburg, Augsburg, Germany
type:PostalAddress
name:Washington University School of Medicine
address:
name:Division of Oncology, Washington University School of Medicine, Saint Louis, USA
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:Amanda Heard
url:http://orcid.org/0000-0002-7150-7998
affiliation:
name:Washington University School of Medicine
address:
name:Division of Oncology, Washington University School of Medicine, Saint Louis, USA
type:PostalAddress
type:Organization
name:Jack H. Landmann
affiliation:
name:Washington University School of Medicine
address:
name:Division of Oncology, Washington University School of Medicine, Saint Louis, USA
type:PostalAddress
type:Organization
name:Ava R. Hansen
url:http://orcid.org/0000-0003-1908-6433
affiliation:
name:Washington University School of Medicine
address:
name:Department of Pediatrics, Washington University School of Medicine, Saint Louis, USA
type:PostalAddress
type:Organization
name:Alkmini Papadopolou
affiliation:
name:University of Augsburg
address:
name:Biochemistry and Molecular Biology, Institute of Theoretical Medicine, Medical Faculty, University of Augsburg, Augsburg, Germany
type:PostalAddress
type:Organization
name:Yu-Sung Hsu
affiliation:
name:Washington University School of Medicine
address:
name:Division of Oncology, Washington University School of Medicine, Saint Louis, USA
type:PostalAddress
type:Organization
name:Mehmet Emrah Selli
url:http://orcid.org/0000-0002-3478-8970
affiliation:
name:Washington University School of Medicine
address:
name:Division of Oncology, Washington University School of Medicine, Saint Louis, USA
type:PostalAddress
type:Organization
name:John M. Warrington
url:http://orcid.org/0000-0001-6066-5491
affiliation:
name:Washington University School of Medicine
address:
name:Division of Oncology, Washington University School of Medicine, Saint Louis, USA
type:PostalAddress
type:Organization
name:John Lattin
affiliation:
name:Washington University School of Medicine
address:
name:Division of Oncology, Washington University School of Medicine, Saint Louis, USA
type:PostalAddress
type:Organization
name:Jufang Chang
affiliation:
name:Washington University School of Medicine
address:
name:Division of Oncology, Washington University School of Medicine, Saint Louis, USA
type:PostalAddress
type:Organization
name:Helen Ha
affiliation:
name:Washington University School of Medicine
address:
name:Division of Oncology, Washington University School of Medicine, Saint Louis, USA
type:PostalAddress
type:Organization
name:Martina Haug-Kroeper
affiliation:
name:University of Augsburg
address:
name:Biochemistry and Molecular Biology, Institute of Theoretical Medicine, Medical Faculty, University of Augsburg, Augsburg, Germany
type:PostalAddress
type:Organization
name:Balraj Doray
url:http://orcid.org/0000-0003-3347-5013
affiliation:
name:Washington University School of Medicine
address:
name:Division of Hematology, Washington University School of Medicine, Saint Louis, USA
type:PostalAddress
type:Organization
name:Saar Gill
affiliation:
name:University of Pennsylvania School of Medicine
address:
name:Division of Hematology and Oncology, University of Pennsylvania School of Medicine, Philadelphia, USA
type:PostalAddress
type:Organization
name:Marco Ruella
url:http://orcid.org/0000-0003-4301-5811
affiliation:
name:University of Pennsylvania School of Medicine
address:
name:Division of Hematology and Oncology, University of Pennsylvania School of Medicine, Philadelphia, USA
type:PostalAddress
type:Organization
name:Katharina E. Hayer
affiliation:
name:The Childrenâs Hospital of Philadelphia
address:
name:Department of Biomedical and Health Informatics, The Childrenâs Hospital of Philadelphia, Philadelphia, USA
type:PostalAddress
type:Organization
name:The Childrenâs Hospital of Philadelphia
address:
name:Department of Pathology and Laboratory Medicine, The Childrenâs Hospital of Philadelphia, Philadelphia, USA
type:PostalAddress
type:Organization
name:Matthew D. Weitzman
url:http://orcid.org/0000-0001-9713-167X
affiliation:
name:The Childrenâs Hospital of Philadelphia
address:
name:Department of Pathology and Laboratory Medicine, The Childrenâs Hospital of Philadelphia, Philadelphia, USA
type:PostalAddress
type:Organization
name:University of Pennsylvania
address:
name:Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA
type:PostalAddress
type:Organization
name:Abby M. Green
affiliation:
name:Washington University School of Medicine
address:
name:Department of Pediatrics, Washington University School of Medicine, Saint Louis, USA
type:PostalAddress
type:Organization
name:Washington University School of Medicine
address:
name:Center for Genome Integrity, Siteman Cancer Center, Washington University School of Medicine, Saint Louis, USA
type:PostalAddress
type:Organization
name:Regina Fluhrer
url:http://orcid.org/0000-0002-9778-4643
affiliation:
name:University of Augsburg
address:
name:Biochemistry and Molecular Biology, Institute of Theoretical Medicine, Medical Faculty, University of Augsburg, Augsburg, Germany
type:PostalAddress
type:Organization
name:Nathan Singh
url:http://orcid.org/0000-0002-0350-7574
affiliation:
name:Washington University School of Medicine
address:
name:Division of Oncology, Washington University School of Medicine, Saint Louis, USA
type:PostalAddress
type:Organization
email:[email protected]
PostalAddress:
name:Division of Oncology, Washington University School of Medicine, Saint Louis, USA
name:Division of Oncology, Washington University School of Medicine, Saint Louis, USA
name:Department of Pediatrics, Washington University School of Medicine, Saint Louis, USA
name:Biochemistry and Molecular Biology, Institute of Theoretical Medicine, Medical Faculty, University of Augsburg, Augsburg, Germany
name:Division of Oncology, Washington University School of Medicine, Saint Louis, USA
name:Division of Oncology, Washington University School of Medicine, Saint Louis, USA
name:Division of Oncology, Washington University School of Medicine, Saint Louis, USA
name:Division of Oncology, Washington University School of Medicine, Saint Louis, USA
name:Division of Oncology, Washington University School of Medicine, Saint Louis, USA
name:Division of Oncology, Washington University School of Medicine, Saint Louis, USA
name:Biochemistry and Molecular Biology, Institute of Theoretical Medicine, Medical Faculty, University of Augsburg, Augsburg, Germany
name:Division of Hematology, Washington University School of Medicine, Saint Louis, USA
name:Division of Hematology and Oncology, University of Pennsylvania School of Medicine, Philadelphia, USA
name:Division of Hematology and Oncology, University of Pennsylvania School of Medicine, Philadelphia, USA
name:Department of Biomedical and Health Informatics, The Childrenâs Hospital of Philadelphia, Philadelphia, USA
name:Department of Pathology and Laboratory Medicine, The Childrenâs Hospital of Philadelphia, Philadelphia, USA
name:Department of Pathology and Laboratory Medicine, The Childrenâs Hospital of Philadelphia, Philadelphia, USA
name:Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA
name:Department of Pediatrics, Washington University School of Medicine, Saint Louis, USA
name:Center for Genome Integrity, Siteman Cancer Center, Washington University School of Medicine, Saint Louis, USA
name:Biochemistry and Molecular Biology, Institute of Theoretical Medicine, Medical Faculty, University of Augsburg, Augsburg, Germany
name:Division of Oncology, Washington University School of Medicine, Saint Louis, USA
Social Networks {👍}(2)
External Links {🔗}(138)
- What's the financial outcome of https://orcid.org/0000-0002-7150-7998?
- How much income is https://orcid.org/0000-0003-1908-6433 earning monthly?
- How much does https://orcid.org/0000-0002-3478-8970 net monthly?
- Learn about the earnings of https://orcid.org/0000-0001-6066-5491
- How profitable is https://orcid.org/0000-0003-3347-5013?
- What are the total earnings of https://orcid.org/0000-0003-4301-5811?
- How much does https://orcid.org/0000-0001-9713-167X net monthly?
- Profit of https://orcid.org/0000-0002-9778-4643
- What is the earnings of https://orcid.org/0000-0002-0350-7574?
- What are the total earnings of http://Benchling.com?
- What are the total earnings of https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE130663?
- What's the financial intake of https://www.rcsb.org/structure/6al5?
- Check the income stats for https://doi.org/10.1056%2FNEJMoa1709866
- How much does http://scholar.google.com/scholar_lookup?&title=Tisagenlecleucel%20in%20children%20and%20young%20adults%20with%20B-cell%20lymphoblastic%20leukemia&journal=N.%20Engl.%20J.%20Med.&doi=10.1056%2FNEJMoa1709866&volume=378&pages=439-448&publication_year=2018&author=Maude%2CSL generate monthly?
- What's the financial outcome of https://doi.org/10.1182%2Fbloodadvances.2020003092?
- What's the monthly income of http://scholar.google.com/scholar_lookup?&title=Real-world%20evidence%20of%20tisagenlecleucel%20for%20pediatric%20acute%20lymphoblastic%20leukemia%20and%20non-Hodgkin%20lymphoma&journal=Blood%20Adv.&doi=10.1182%2Fbloodadvances.2020003092&volume=4&pages=5414-5424&publication_year=2020&author=Pasquini%2CMC?
- What's the monthly money flow for https://doi.org/10.1056%2FNEJMoa1804980?
- How much does http://scholar.google.com/scholar_lookup?&title=Tisagenlecleucel%20in%20adult%20relapsed%20or%20refractory%20diffuse%20large%20B-cell%20lymphoma&journal=N.%20Engl.%20J.%20Med.&doi=10.1056%2FNEJMoa1804980&volume=380&pages=45-56&publication_year=2019&author=Schuster%2CSJ pull in?
- Find out how much https://doi.org/10.1056%2FNEJMoa1707447 earns monthly
- How much income is http://scholar.google.com/scholar_lookup?&title=Axicabtagene%20ciloleucel%20CAR%20T-cell%20therapy%20in%20refractory%20large%20B-cell%20lymphoma&journal=N.%20Engl.%20J.%20Med.&doi=10.1056%2FNEJMoa1707447&volume=377&pages=2531-2544&publication_year=2017&author=Neelapu%2CSS earning monthly?
- How much income is https://doi.org/10.1200%2FJCO.19.02104 earning monthly?
- http://scholar.google.com/scholar_lookup?&title=Standard-of-care%20axicabtagene%20ciloleucel%20for%20relapsed%20or%20refractory%20large%20B-cell%20lymphoma%3A%20results%20from%20the%20US%20lymphoma%20CAR%20T%20consortium&journal=J.%20Clin.%20Oncol.&doi=10.1200%2FJCO.19.02104&volume=38&pages=3119-3128&publication_year=2020&author=Nastoupil%2CLJ's financial summary
- What's the income of https://doi.org/10.1126%2Fscitranslmed.aac5415?
- http://scholar.google.com/scholar_lookup?&title=Chimeric%20antigen%20receptor%20T%20cells%20persist%20and%20induce%20sustained%20remissions%20in%20relapsed%20refractory%20chronic%20lymphocytic%20leukemia&journal=Sci.%20Transl.%20Med.&doi=10.1126%2Fscitranslmed.aac5415&volume=7&publication_year=2015&author=Porter%2CDL's financial summary
- What is the earnings of https://doi.org/10.1056%2FNEJMoa1914347?
- Explore the financials of http://scholar.google.com/scholar_lookup?&title=KTE-X19%20CAR%20T-cell%20therapy%20in%20relapsed%20or%20refractory%20mantle-cell%20lymphoma&journal=N.%20Engl.%20J.%20Med.&doi=10.1056%2FNEJMoa1914347&volume=382&pages=1331-1342&publication_year=2020&author=Wang%2CM
- How much does https://doi.org/10.1016%2FS1470-2045%2818%2930864-7 rake in every month?
- How much does http://scholar.google.com/scholar_lookup?&title=Long-term%20safety%20and%20activity%20of%20axicabtagene%20ciloleucel%20in%20refractory%20large%20B-cell%20lymphoma%20%28ZUMA-1%29%3A%20a%20single-arm%2C%20multicentre%2C%20phase%201-2%20trial&journal=Lancet%20Oncol.&doi=10.1016%2FS1470-2045%2818%2930864-7&volume=20&pages=31-42&publication_year=2019&author=Locke%2CFL earn?
- https://doi.org/10.1038%2Fs41591-018-0010-1's revenue stream
- How much profit is http://scholar.google.com/scholar_lookup?&title=Determinants%20of%20response%20and%20resistance%20to%20CD19%20chimeric%20antigen%20receptor%20%28CAR%29%20T%20cell%20therapy%20of%20chronic%20lymphocytic%20leukemia&journal=Nat.%20Med.&doi=10.1038%2Fs41591-018-0010-1&volume=24&pages=563-571&publication_year=2018&author=Fraietta%2CJA making per month?
- How much does https://doi.org/10.1038%2Fs41591-020-1061-7 bring in each month?
- Revenue of http://scholar.google.com/scholar_lookup?&title=Characteristics%20of%20anti-CD19%20CAR%20T%20cell%20infusion%20products%20associated%20with%20efficacy%20and%20toxicity%20in%20patients%20with%20large%20B%20cell%20lymphomas&journal=Nat.%20Med.&doi=10.1038%2Fs41591-020-1061-7&volume=26&pages=1878-1887&publication_year=2020&author=Deng%2CQ
- How much money does https://doi.org/10.1038%2Fs41467-019-13880-1 generate?
- Discover the revenue of http://adsabs.harvard.edu/cgi-bin/nph-data_query?link_type=ABSTRACT&bibcode=2020NatCo..11..219S
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Clonal%20kinetics%20and%20single-cell%20transcriptional%20profiling%20of%20CAR-T%20cells%20in%20patients%20undergoing%20CD19%20CAR-T%20immunotherapy&journal=Nat.%20Commun.&doi=10.1038%2Fs41467-019-13880-1&volume=11&publication_year=2020&author=Sheih%2CA produce monthly?
- How much money does http://scholar.google.com/scholar_lookup?&title=Early%20memory%20phenotypes%20drive%20T%20cell%20proliferation%20in%20patients%20with%20pediatric%20malignancies&journal=Sci.%20Transl.%20Med.&volume=8&publication_year=2016&author=Singh%2CN&author=Perazzelli%2CJ&author=Grupp%2CSA&author=Barrett%2CDM generate?
- What is the earnings of https://doi.org/10.1158%2F2159-8290.CD-19-0813?
- How much cash flow does http://scholar.google.com/scholar_lookup?&title=Impaired%20death%20receptor%20signaling%20in%20leukemia%20causes%20antigen-independent%20resistance%20by%20inducing%20CAR%20T-cell%20dysfunction&journal=Cancer%20Disco.&doi=10.1158%2F2159-8290.CD-19-0813&volume=10&pages=552-567&publication_year=2020&author=Singh%2CN have monthly?
- What's the financial intake of https://doi.org/10.1016%2Fj.semcancer.2019.12.002?
- http://scholar.google.com/scholar_lookup?&title=Mechanisms%20of%20resistance%20to%20CAR%20T%20cell%20therapies&journal=Semin.%20Cancer%20Biol.&doi=10.1016%2Fj.semcancer.2019.12.002&volume=65&pages=91-98&publication_year=2020&author=Singh%2CN's financial summary
- https://doi.org/10.1038%2Fs41591-018-0146-z income
- How much profit does http://scholar.google.com/scholar_lookup?&title=Genetic%20mechanisms%20of%20target%20antigen%20loss%20in%20CAR19%20therapy%20of%20acute%20lymphoblastic%20leukemia&journal=Nat.%20Med.&doi=10.1038%2Fs41591-018-0146-z&volume=24&pages=1504-1506&publication_year=2018&author=Orlando%2CEJ generate?
- How much revenue does https://doi.org/10.1158%2F2159-8290.CD-15-1020 produce monthly?
- See how much http://scholar.google.com/scholar_lookup?&title=Convergence%20of%20acquired%20mutations%20and%20alternative%20splicing%20of%20CD19%20enables%20resistance%20to%20CART-19%20immunotherapy&journal=Cancer%20Disco.&doi=10.1158%2F2159-8290.CD-15-1020&volume=5&pages=1282-1295&publication_year=2015&author=Sotillo%2CE makes per month
- What's the total monthly financial gain of https://doi.org/10.15252%2Fembj.201488375?
- How much does http://scholar.google.com/scholar_lookup?&title=Shedding%20of%20glycan-modifying%20enzymes%20by%20signal%20peptide%20peptidase-like%203%20%28SPPL3%29%20regulates%20cellular%20N-glycosylation&journal=EMBO%20J.&doi=10.15252%2Fembj.201488375&volume=33&pages=2890-2905&publication_year=2014&author=Voss%2CM pull in?
- Learn how profitable https://doi.org/10.1074%2Fmcp.M115.048298 is on a monthly basis
- http://scholar.google.com/scholar_lookup?&title=Secretome%20analysis%20identifies%20novel%20signal%20Peptide%20peptidase-like%203%20%28Sppl3%29%20substrates%20and%20reveals%20a%20role%20of%20Sppl3%20in%20multiple%20Golgi%20glycosylation%20pathways&journal=Mol.%20Cell%20Proteom.&doi=10.1074%2Fmcp.M115.048298&volume=14&pages=1584-1598&publication_year=2015&author=Kuhn%2CPH's revenue stream
- How much profit does https://doi.org/10.1016%2Fj.immuni.2016.05.014 generate?
- Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=Engineered%20CAR%20T%20cells%20targeting%20the%20cancer-associated%20Tn-glycoform%20of%20the%20membrane%20mucin%20MUC1%20control%20adenocarcinoma&journal=Immunity&doi=10.1016%2Fj.immuni.2016.05.014&volume=44&pages=1444-1454&publication_year=2016&author=Posey%2CAD
- Explore the financials of https://doi.org/10.1038%2Fnbt.3437
- Income figures for http://scholar.google.com/scholar_lookup?&title=Optimized%20sgRNA%20design%20to%20maximize%20activity%20and%20minimize%20off-target%20effects%20of%20CRISPR-Cas9&journal=Nat.%20Biotechnol.&doi=10.1038%2Fnbt.3437&volume=34&pages=184-191&publication_year=2016&author=Doench%2CJG
- Find out how much https://doi.org/10.1021%2Facs.biochem.9b00808 earns monthly
- What is the earnings of http://scholar.google.com/scholar_lookup?&title=Fine%20epitope%20mapping%20of%20the%20CD19%20extracellular%20domain%20promotes%20design&journal=Biochemistry&doi=10.1021%2Facs.biochem.9b00808&volume=58&pages=4869-4881&publication_year=2019&author=Klesmith%2CJR&author=Wu%2CL&author=Lobb%2CRR&author=Rennert%2CPD&author=Hackel%2CBJ?
- How much money does https://doi.org/10.1038%2Fs41591-021-01436-0 make?
- How much does http://scholar.google.com/scholar_lookup?&title=CAR%20T%20cells%20with%20dual%20targeting%20of%20CD19%20and%20CD22%20in%20adult%20patients%20with%20recurrent%20or%20refractory%20B%20cell%20malignancies%3A%20a%20phase%201%20trial&journal=Nat.%20Med.&doi=10.1038%2Fs41591-021-01436-0&volume=27&pages=1419-1431&publication_year=2021&author=Spiegel%2CJY bring in each month?
- How much does https://doi.org/10.1038%2Fnm.4441 gross monthly?
- How much does http://scholar.google.com/scholar_lookup?&title=CD22-targeted%20CAR%20T%20cells%20induce%20remission%20in%20B-ALL%20that%20is%20naive%20or%20resistant%20to%20CD19-targeted%20CAR%20immunotherapy&journal=Nat.%20Med.&doi=10.1038%2Fnm.4441&volume=24&pages=20-28&publication_year=2018&author=Fry%2CTJ generate monthly?
- Get to know https://doi.org/10.1038%2Fs41591-021-01326-5's earnings
- How much money does http://scholar.google.com/scholar_lookup?&title=Antigen-independent%20activation%20enhances%20the%20efficacy%20of%204-1BB-costimulated%20CD22%20CAR%20T%20cells&journal=Nat.%20Med.&doi=10.1038%2Fs41591-021-01326-5&volume=27&pages=842-850&publication_year=2021&author=Singh%2CN generate?
- What is the earnings of https://doi.org/10.1073%2Fpnas.172380699?
- How profitable is http://adsabs.harvard.edu/cgi-bin/nph-data_query?link_type=ABSTRACT&bibcode=2002PNAS...9910231H?
- Earnings of http://scholar.google.com/scholar_lookup?&title=Glycosylation%20defining%20cancer%20malignancy%3A%20new%20wine%20in%20an%20old%20bottle&journal=Proc.%20Natl%20Acad.%20Sci.%20USA&doi=10.1073%2Fpnas.172380699&volume=99&pages=10231-10233&publication_year=2002&author=Hakomori%2CS
- What's the income of https://doi.org/10.1038%2Fnrc3982?
- What's the profit of http://scholar.google.com/scholar_lookup?&title=Glycosylation%20in%20cancer%3A%20mechanisms%20and%20clinical%20implications&journal=Nat.%20Rev.%20Cancer&doi=10.1038%2Fnrc3982&volume=15&pages=540-555&publication_year=2015&author=Pinho%2CSS&author=Reis%2CCA?
- What's https://doi.org/10.1126%2Fscitranslmed.abg3072's gross income?
- How much does http://scholar.google.com/scholar_lookup?&title=Disrupting%20N-glycan%20expression%20on%20tumor%20cells%20boosts%20chimeric%20antigen%20receptor%20T%20cell%20efficacy%20against%20solid%20malignancies&journal=Sci.%20Transl.%20Med.&doi=10.1126%2Fscitranslmed.abg3072&volume=14&publication_year=2022&author=Greco%2CB make?
- What's the financial gain of https://doi.org/10.1016%2Fj.immuni.2020.11.003?
- How much income does http://scholar.google.com/scholar_lookup?&title=The%20SPPL3-defined%20glycosphingolipid%20repertoire%20orchestrates%20HLA%20class%20I-mediated%20immune%20responses&journal=Immunity&doi=10.1016%2Fj.immuni.2020.11.003&volume=54&pages=132-150%20e139&publication_year=2021&author=Jongsma%2CMLM have?
- Profit of https://doi.org/10.1126%2Fscience.1247005
- What's the financial outcome of http://adsabs.harvard.edu/cgi-bin/nph-data_query?link_type=ABSTRACT&bibcode=2014Sci...343...84S?
- What's the income of http://scholar.google.com/scholar_lookup?&title=Genome-scale%20CRISPR-Cas9%20knockout%20screening%20in%20human%20cells&journal=Science&doi=10.1126%2Fscience.1247005&volume=343&pages=84-87&publication_year=2014&author=Shalem%2CO?
- Check the income stats for https://link.springer.com/doi/10.1186/s13059-015-0843-6
- What are the earnings of http://scholar.google.com/scholar_lookup?&title=Quality%20control%2C%20modeling%2C%20and%20visualization%20of%20CRISPR%20screens%20with%20MAGeCK-VISPR&journal=Genome%20Biol.&doi=10.1186%2Fs13059-015-0843-6&volume=16&publication_year=2015&author=Li%2CW?
- Explore the financials of https://link.springer.com/doi/10.1186/s13059-014-0554-4
- Find out how much http://scholar.google.com/scholar_lookup?&title=MAGeCK%20enables%20robust%20identification%20of%20essential%20genes%20from%20genome-scale%20CRISPR%2FCas9%20knockout%20screens&journal=Genome%20Biol.&doi=10.1186%2Fs13059-014-0554-4&volume=15&publication_year=2014&author=Li%2CW earns monthly
- How much does https://doi.org/10.1093%2Fnar%2Fgku936 generate monthly?
- What's the total monthly financial gain of http://scholar.google.com/scholar_lookup?&title=Easy%20quantitative%20assessment%20of%20genome%20editing%20by%20sequence%20trace%20decomposition&journal=Nucleic%20Acids%20Res.&doi=10.1093%2Fnar%2Fgku936&volume=42&publication_year=2014&author=Brinkman%2CEK&author=Chen%2CT&author=Amendola%2CM&author=Steensel%2CB?
- https://doi.org/10.1016%2Fj.jim.2016.01.007's financial summary
- What's http://scholar.google.com/scholar_lookup?&title=Assessment%20of%20costimulation%20and%20coinhibition%20in%20a%20triple%20parameter%20T%20cell%20reporter%20line%3A%20Simultaneous%20measurement%20of%20NF-kappaB%2C%20NFAT%20and%20AP-1&journal=J.%20Immunol.%20Methods&doi=10.1016%2Fj.jim.2016.01.007&volume=430&pages=10-20&publication_year=2016&author=Jutz%2CS's gross income?
- How much income is https://doi.org/10.1002%2Fjcc.20084 earning monthly?
- What is the monthly revenue of http://scholar.google.com/scholar_lookup?&title=UCSF%20Chimera%E2%80%94a%20visualization%20system%20for%20exploratory%20research%20and%20analysis&journal=J.%20Comput.%20Chem.&doi=10.1002%2Fjcc.20084&volume=25&pages=1605-1612&publication_year=2004&author=Pettersen%2CEF?
- What's the profit of https://citation-needed.springer.com/v2/references/10.1038/s41467-022-31035-7?format=refman&flavour=references?
- How much income is https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Amanda%20Heard earning monthly?
- What are the earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Amanda%20Heard%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- Find out how much https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Jack%20H.%20Landmann earns monthly
- https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Jack%20H.%20Landmann%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's financial summary
- Find out how much https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Ava%20R.%20Hansen earns monthly
- What's the financial intake of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Ava%20R.%20Hansen%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Alkmini%20Papadopolou pull in monthly?
- How much revenue does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Alkmini%20Papadopolou%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en bring in?
- Discover the revenue of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Yu-Sung%20Hsu
- How much revenue does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Yu-Sung%20Hsu%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en bring in?
- Revenue of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Mehmet%20Emrah%20Selli
- Income figures for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Mehmet%20Emrah%20Selli%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=John%20M.%20Warrington make?
- https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22John%20M.%20Warrington%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's revenue stream
- What's the revenue for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=John%20Lattin?
- What is the earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22John%20Lattin%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- Explore the financials of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Jufang%20Chang
- How much profit is https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Jufang%20Chang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en making per month?
- Get to know https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Helen%20Ha's earnings
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Helen%20Ha%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en rake in every month?
- What's the financial intake of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Martina%20Haug-Kroeper?
- How much profit does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Martina%20Haug-Kroeper%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate?
- How much income is https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Balraj%20Doray earning monthly?
- See how much https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Balraj%20Doray%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en makes per month
- Find out how much https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Saar%20Gill earns monthly
- How much profit does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Saar%20Gill%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en make?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Marco%20Ruella bring in each month?
- What's the profit of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Marco%20Ruella%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- Explore the financials of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Katharina%20E.%20Hayer
- What's the total monthly financial gain of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Katharina%20E.%20Hayer%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- Income figures for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Matthew%20D.%20Weitzman
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Matthew%20D.%20Weitzman%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate monthly?
- Check the income stats for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Abby%20M.%20Green
- How much money does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Abby%20M.%20Green%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate?
- Learn how profitable https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Regina%20Fluhrer is on a monthly basis
- Get to know https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Regina%20Fluhrer%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's earnings
- What's the monthly income of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Nathan%20Singh?
- What's the total monthly financial gain of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Nathan%20Singh%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- What's the financial outcome of https://static-content.springer.com/esm/art%3A10.1038%2Fs41467-022-31035-7/MediaObjects/41467_2022_31035_MOESM1_ESM.pdf?
- How much revenue does https://static-content.springer.com/esm/art%3A10.1038%2Fs41467-022-31035-7/MediaObjects/41467_2022_31035_MOESM2_ESM.pdf bring in?
- Earnings of https://static-content.springer.com/esm/art%3A10.1038%2Fs41467-022-31035-7/MediaObjects/41467_2022_31035_MOESM3_ESM.pdf
- Financial intake of https://static-content.springer.com/esm/art%3A10.1038%2Fs41467-022-31035-7/MediaObjects/41467_2022_31035_MOESM4_ESM.xlsx
- How much profit does http://creativecommons.org/licenses/by/4.0/ generate?
- How much income is https://s100.copyright.com/AppDispatchServlet?title=Antigen%20glycosylation%20regulates%20efficacy%20of%20CAR%20T%20cells%20targeting%20CD19&author=Amanda%20Heard%20et%20al&contentID=10.1038%2Fs41467-022-31035-7©right=The%20Author%28s%29&publication=2041-1723&publicationDate=2022-06-11&publisherName=SpringerNature&orderBeanReset=true&oa=CC%20BY earning monthly?
- How much does https://crossmark.crossref.org/dialog/?doi=10.1038/s41467-022-31035-7 generate monthly?
- What's https://citation-needed.springer.com/v2/references/10.1038/s41467-022-31035-7?format=refman&flavour=citation's gross income?
- How much does https://doi.org/10.1186/s12943-025-02334-6 net monthly?
- How much revenue does https://doi.org/10.1038/s41409-024-02463-4 generate?
- Check the income stats for https://doi.org/10.1007/s10555-024-10232-4
- How much money does https://doi.org/10.1038/s41467-025-56547-w make?
- How much revenue does https://doi.org/10.1038/s41392-024-01886-1 produce monthly?
- What's the profit of https://www.protocols.io/?
- Find out how much https://www.natureindex.com/ earns monthly
- Monthly income for http://www.naturechina.com
- https://www.natureasia.com/ja-jp income
Analytics and Tracking {📊}
- Google Tag Manager
Libraries {📚}
- Backbone.js
- Prism.js
- Zoom.js
Emails and Hosting {✉️}
Mail Servers:
- mxa-002c5801.gslb.pphosted.com
- mxb-002c5801.gslb.pphosted.com
Name Servers:
- pdns1.ultradns.net
- pdns2.ultradns.net
- pdns3.ultradns.org
- pdns4.ultradns.org
- pdns5.ultradns.info
- pdns6.ultradns.co.uk
CDN Services {📦}
- Crossref